局部-话题@MedSci

#局部#

598篇内容 | 2765人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1405953, encodeId=36f414059535f, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=默克和辉瑞的抗PD-L1单抗Bavencio改善了局部晚期或转移性尿路上皮癌患者的生存率：III期临床达到主要终点, objectType=article, longId=185843, objectId=5f5518584350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5518584350, replyNumber=0, likeNumber=16, createdTime=2020-01-08, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5518584350, moduleTitle=默克和辉瑞的抗PD-L1单抗Bavencio改善了局部晚期或转移性尿路上皮癌患者的生存率：III期临床达到主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f5518584350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405952, encodeId=2c911405952d5, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Clin Oncol：局部前列腺癌中雄激素阻断治疗和外束放射治疗顺序研究, objectType=article, longId=185828, objectId=79fd185828b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79fd185828b2, replyNumber=0, likeNumber=66, createdTime=2020-01-08, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79fd185828b2, moduleTitle=J Clin Oncol：局部前列腺癌中雄激素阻断治疗和外束放射治疗顺序研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79fd185828b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405951, encodeId=61301405951b1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=J Clin Oncol：局部前列腺癌的分子生物标记：ASCO指南, objectType=article, longId=185761, objectId=bb22185e613a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb22185e613a, replyNumber=0, likeNumber=69, createdTime=2020-01-07, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb22185e613a, moduleTitle=J Clin Oncol：局部前列腺癌的分子生物标记：ASCO指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb22185e613a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405950, encodeId=ca661405950cb, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效, objectType=article, longId=185410, objectId=e22b185410d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e22b185410d3, replyNumber=0, likeNumber=57, createdTime=2019-12-31, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e22b185410d3, moduleTitle=JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e22b185410d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405949, encodeId=eba91405949cf, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur Urol：局部前列腺癌患者中的10年死亡率、疾病恶化和治疗相关副作用分析, objectType=article, longId=184474, objectId=7bc61844e404, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bc61844e404, replyNumber=0, likeNumber=100, createdTime=2019-12-11, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bc61844e404, moduleTitle=Eur Urol：局部前列腺癌患者中的10年死亡率、疾病恶化和治疗相关副作用分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bc61844e404)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405948, encodeId=666614059486a, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, objectType=article, longId=184137, objectId=74cc18413e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74cc18413e05, replyNumber=0, likeNumber=73, createdTime=2019-12-05, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74cc18413e05, moduleTitle=PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74cc18413e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405947, encodeId=70ca140594ede, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=病例：联合靶向和局部治疗用于Ⅲb期肝癌患者，展现出良好效果, objectType=article, longId=183980, objectId=27ae18398071, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27ae18398071, replyNumber=0, likeNumber=60, createdTime=2019-12-04, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27ae18398071, moduleTitle=病例：联合靶向和局部治疗用于Ⅲb期肝癌患者，展现出良好效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27ae18398071)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405946, encodeId=360f140594673, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Eur Urol：恶性前列腺癌根治性放疗后局部失败和生存研究, objectType=article, longId=183551, objectId=ef4f183551b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef4f183551b0, replyNumber=0, likeNumber=73, createdTime=2019-11-26, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef4f183551b0, moduleTitle=Eur Urol：恶性前列腺癌根治性放疗后局部失败和生存研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef4f183551b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405945, encodeId=28f9140594538, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=FDA 发布透皮和局部递药系统研发和质量考量指南草案, objectType=article, longId=183461, objectId=be6c1834611b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be6c1834611b, replyNumber=0, likeNumber=64, createdTime=2019-11-24, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be6c1834611b, moduleTitle=FDA 发布透皮和局部递药系统研发和质量考量指南草案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be6c1834611b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405944, encodeId=bbbe1405944dd, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=2019 EULAR建议：干燥综合征的局部和全身治疗, objectType=article, longId=182413, objectId=082a182413ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=082a182413ac, replyNumber=0, likeNumber=10, createdTime=2019-11-06, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=082a182413ac, moduleTitle=2019 EULAR建议：干燥综合征的局部和全身治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=082a182413ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405943, encodeId=cf99140594300, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Urol Oncol：局部前列腺癌治疗高强度聚焦超声（HIFU）治疗的前瞻性多中心研究, objectType=article, longId=182104, objectId=f5b618210448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5b618210448, replyNumber=0, likeNumber=49, createdTime=2019-10-30, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5b618210448, moduleTitle=Urol Oncol：局部前列腺癌治疗高强度聚焦超声（HIFU）治疗的前瞻性多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5b618210448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405942, encodeId=4a98140594282, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=唇缺损局部组织瓣修复重建专家共识, objectType=article, longId=182008, objectId=f2781820088b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2781820088b, replyNumber=0, likeNumber=12, createdTime=2019-10-28, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2781820088b, moduleTitle=唇缺损局部组织瓣修复重建专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2781820088b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405941, encodeId=ee2814059410b, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Pamrevlumab治疗局部晚期胰腺癌的III期临床试验正式开始, objectType=article, longId=181869, objectId=b55d181869fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b55d181869fc, replyNumber=0, likeNumber=10, createdTime=2019-10-26, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b55d181869fc, moduleTitle=Pamrevlumab治疗局部晚期胰腺癌的III期临床试验正式开始, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b55d181869fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405940, encodeId=8bf3140594059, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Lancet：乳腺癌局部或全麻后复发风险研究, objectType=article, longId=181699, objectId=094e181699bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094e181699bc, replyNumber=0, likeNumber=61, createdTime=2019-10-23, rootId=0, userName=智智灵药, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094e181699bc, moduleTitle=Lancet：乳腺癌局部或全麻后复发风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094e181699bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405939, encodeId=4db61405939da, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=局部用米诺环素Foamix获得FDA批准，治疗数百万中度至重度痤疮患者, objectType=article, longId=181607, objectId=95ab18160e51, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95ab18160e51, replyNumber=0, likeNumber=59, createdTime=2019-10-21, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95ab18160e51, moduleTitle=局部用米诺环素Foamix获得FDA批准，治疗数百万中度至重度痤疮患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95ab18160e51)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405938, encodeId=cc101405938f9, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=Dent Mater J：可摘局部义齿固位体和大连接体设计对活动牙稳定的影响：一项初步研究, objectType=article, longId=181040, objectId=53341810403e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53341810403e, replyNumber=0, likeNumber=56, createdTime=2019-10-14, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53341810403e, moduleTitle=Dent Mater J：可摘局部义齿固位体和大连接体设计对活动牙稳定的影响：一项初步研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53341810403e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405937, encodeId=1911140593e61, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌, objectType=article, longId=181035, objectId=c7c318103504, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7c318103504, replyNumber=0, likeNumber=103, createdTime=2019-10-14, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7c318103504, moduleTitle=【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7c318103504)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405936, encodeId=1670140593679, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=局部晚期胃癌优化治疗模式的探寻, objectType=article, longId=181034, objectId=0902181034b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0902181034b7, replyNumber=0, likeNumber=0, createdTime=2019-10-14, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0902181034b7, moduleTitle=局部晚期胃癌优化治疗模式的探寻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0902181034b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405935, encodeId=275b1405935c3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=局部放疗在晚期NSCLC中的应用价值, objectType=article, longId=180958, objectId=63f2180958fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63f2180958fd, replyNumber=0, likeNumber=56, createdTime=2019-10-13, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63f2180958fd, moduleTitle=局部放疗在晚期NSCLC中的应用价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63f2180958fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1405934, encodeId=2f6a1405934a1, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, objectTitle=骨搬运技术联合局部载庆大霉素硫酸钙治疗胫骨感染性骨不连1例, objectType=article, longId=180621, objectId=8c66180621dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c66180621dc, replyNumber=0, likeNumber=71, createdTime=2019-10-08, rootId=0, userName=chg122, userId=d14c2562456, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c66180621dc, moduleTitle=骨搬运技术联合局部载庆大霉素硫酸钙治疗胫骨感染性骨不连1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c66180621dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

局部

2020-05-29

chg122 (审核中...)

前往app查看评论内容

#局部#

默克和辉瑞的抗PD-L1单抗Bavencio改善了局部晚期或转移性尿路上皮癌患者的生存率：III期临床达到主要终点

2020-01-08

chg122 (审核中...)

前往app查看评论内容

#局部#

J Clin Oncol：局部前列腺癌中雄激素阻断治疗和外束放射治疗顺序研究

2020-01-08

chg122 (审核中...)

前往app查看评论内容

#局部#

J Clin Oncol：局部前列腺癌的分子生物标记：ASCO指南

2020-01-07

chg122 (审核中...)

前往app查看评论内容

#局部#

JAMA Surg：新辅助化疗后腹腔镜远端局部晚期胃癌的疗效

2019-12-31

智智灵药 (审核中...)

前往app查看评论内容

#局部#

Eur Urol：局部前列腺癌患者中的10年死亡率、疾病恶化和治疗相关副作用分析

2019-12-11

智智灵药 (审核中...)

前往app查看评论内容

#局部#

PD-1单抗单药治疗双原发癌，局部晚期肺鳞癌肿瘤疗效PR，肝细胞癌肿瘤疗效评估pCR

2019-12-05

智智灵药 (审核中...)

前往app查看评论内容

#局部#

病例：联合靶向和局部治疗用于Ⅲb期肝癌患者，展现出良好效果

2019-12-04

智智灵药 (审核中...)

前往app查看评论内容

#局部#

Eur Urol：恶性前列腺癌根治性放疗后局部失败和生存研究

2019-11-26

智智灵药 (审核中...)

前往app查看评论内容

#局部#

FDA 发布透皮和局部递药系统研发和质量考量指南草案

2019-11-24

智智灵药 (审核中...)

前往app查看评论内容

#局部#

2019 EULAR建议：干燥综合征的局部和全身治疗

2019-11-06

智智灵药 (审核中...)

前往app查看评论内容

#局部#

Urol Oncol：局部前列腺癌治疗高强度聚焦超声（HIFU）治疗的前瞻性多中心研究

2019-10-30

智智灵药 (审核中...)

前往app查看评论内容

#局部#

唇缺损局部组织瓣修复重建专家共识

2019-10-28

智智灵药 (审核中...)

前往app查看评论内容

#局部#

Pamrevlumab治疗局部晚期胰腺癌的III期临床试验正式开始

2019-10-26

智智灵药 (审核中...)

前往app查看评论内容

#局部#

Lancet：乳腺癌局部或全麻后复发风险研究

2019-10-23

chg122 (审核中...)

前往app查看评论内容

#局部#

局部用米诺环素Foamix获得FDA批准，治疗数百万中度至重度痤疮患者

2019-10-21

chg122 (审核中...)

前往app查看评论内容

#局部#

Dent Mater J：可摘局部义齿固位体和大连接体设计对活动牙稳定的影响：一项初步研究

2019-10-14

chg122 (审核中...)

前往app查看评论内容

#局部#

【2019 ESMO】放化疗联合帕博利珠单抗治疗局部晚期食管鳞癌

2019-10-14

chg122 (审核中...)

前往app查看评论内容

#局部#

局部晚期胃癌优化治疗模式的探寻

2019-10-14

chg122 (审核中...)

前往app查看评论内容

#局部#

局部放疗在晚期NSCLC中的应用价值

2019-10-13

chg122 (审核中...)

前往app查看评论内容

#局部#

骨搬运技术联合局部载庆大霉素硫酸钙治疗胫骨感染性骨不连1例

2019-10-08

科室
- - 订阅+
  - 更多科室
工具
服务